Aspen-01: A Phase 1 Study Of Alx148, A Cd47 Blocker, In Combination With Trastuzumab, Ramucirumab And Paclitaxel In Patients With Second-Line Her2-Positive Advanced Gastric Or Gastroesophageal Junction Cancer
ANNALS OF ONCOLOGY(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要